U.S. Retail REITs Stock News

NasdaqGS:NOVT
NasdaqGS:NOVTElectronic

Novanta (NOVT) Completes Riverpoint Medical Deal To Expand Recurring Consumables Revenue

Novanta (NasdaqGS:NOVT) has completed its acquisition of Riverpoint Medical. The deal significantly increases Novanta's exposure to the medical consumables market. Management expects the transaction to approximately double recurring medical consumables revenue. Novanta focuses on precision photonics, vision and motion technologies used in medical and advanced industrial applications. With Riverpoint Medical now under its umbrella, the company gains a larger footprint in medical consumables,...
NasdaqGM:ETON
NasdaqGM:ETONPharmaceuticals

Is Eton Pharmaceuticals (ETON) Quietly Reframing Its Orphan-Drug Strategy With KHINDIVI’s Label Expansion Bid?

Eton Pharmaceuticals has submitted a Prior Approval Supplement to the FDA seeking to extend KHINDIVI’s hydrocortisone oral solution label to younger pediatric patients with adrenocortical insufficiency, beyond its current approval for those aged five and older. This move, backed by bioequivalence data versus ALKINDI SPRINKLE, could broaden treatment options in a rare disease population where Eton estimates about 10,000 U.S. pediatric patients. With KHINDIVI already the only FDA-approved...
NYSE:PNR
NYSE:PNRMachinery

Pentair (PNR) Stock May Be A Bargain Following Fraud Probe Fallout

Pentair stock has fallen sharply this year, yet the company still screens as undervalued on several key checks, including an intrinsic value estimate that sits well above the current share price. With sentiment hit by legal investigations and weaker trading in parts of the business, investors are weighing whether the current discount fairly reflects the risks now in play. Year to date, Pentair shares are down 36.9%, which means current holders have taken a sizeable hit and new investors are...
NYSE:BSX
NYSE:BSXMedical Equipment

Low Volatility Stocks Investors Are Watching As Fed Rate Signals Turn Less Clear

Fed Chair Kevin Warsh’s move to dial back forward guidance has left markets more data driven and, at times, more jumpy. When rate clues are harder to read, many investors start to focus on stocks that have shown relatively low price swings and steadier profiles. That is where a low volatility screener can help filter the chaos. This article looks at three stocks from that list that appear positively exposed to the current policy uncertainty and recent volatility in Treasury yields, and...
NasdaqGS:ADBE
NasdaqGS:ADBESoftware

Adobe (ADBE) Joins Open Source AI Cybersecurity Alliance As AI Security Effort Expands

Adobe, ticker NasdaqGS:ADBE, has joined a new coalition to launch the Open Source AI Cybersecurity Alliance. The alliance focuses on open source collaboration to improve cybersecurity for artificial intelligence systems. This company initiative has not been widely covered in recent Adobe news as of July 2026. Adobe is best known for its creative and digital experience software, but its role in AI has been growing across products and services. Joining the Open Source AI Cybersecurity...
NasdaqGS:ADP
NasdaqGS:ADPProfessional Services

ADP Stock And 2 HR Software Picks For Rising Compliance Demand

Investors watching the latest Goldman Sachs tribunal decision on sex discrimination and unfair dismissal can see how quickly employment disputes turn into real financial and reputational costs. Human resources and employment law services sit close to this pressure point, from compliance advice to managing workplace disputes. When a £1.45mn award and critical findings on dismissal processes hit headlines, that can influence how companies think about risk management and where they spend on...
NYSE:IT
NYSE:ITIT

Gartner (IT) Stock May Sit Below Fair Value Despite Fresh AI Demand News

Gartner stock has had a tough run over the past year, yet current valuation checks suggest the share price may now sit below what its Discounted Cash Flow (DCF) and earnings multiple signals imply for intrinsic value. Over the past 12 months the share price has fallen 51.8%, which puts recent gains into context and raises the question of whether sentiment has moved further than the fundamentals. Recent headlines around Gartner's AI forecasts and its role in shaping spending on AI...
NYSE:IP
NYSE:IPPackaging

International Paper (IP) Stock Looks Undervalued On Fair Value But Richer On Sales

International Paper has delivered a 33.3% gain over the past three years, yet the stock still screens as undervalued on key valuation checks, which puts the recent price moves and containerboard news in sharp focus for investors. A 33.3% return over three years suggests International Paper has already rewarded patient shareholders. The question is whether the current price still leaves room for further upside or now embeds much of that progress. Recent containerboard price increase plans and...
NYSE:COF
NYSE:COFConsumer Finance

Synchrony Financial Stock And Two Consumer Lenders Under Pressure From High Rates

Consumer lending stocks are feeling the strain as the Federal Reserve holds rates steady and energy driven inflation keeps household budgets tight. With borrowing costs elevated and credit cards, auto loans, and mortgages all putting pressure on consumers, some companies exposed to this news are facing tougher conditions than others. This article focuses on three consumer lending stocks that appear more vulnerable to the current rate and inflation backdrop. Each section explains how the...
NYSE:TFX
NYSE:TFXMedical Equipment

Teleflex (TFX) Wins FDA Approval For EZPLAZ, Is The Stock Still Below Fair Value?

Why Teleflex Stock Is Back in Focus After EZPLAZ FDA Approval Teleflex (TFX) is drawing fresh attention after the U.S. Food and Drug Administration approved EZPLAZ Freeze Dried Plasma, the first FDA licensed freeze dried plasma product for urgent bleeding situations. The approval gives Teleflex its first biologics license for a blood component and introduces a plasma option designed for environments where traditional frozen products are hard to store or prepare, including battlefield and...
NasdaqGS:CCEC
NasdaqGS:CCECShipping

Is Capital Clean Energy Carriers (CCEC) Fairly Valued As Q2 Earnings Show Higher Sales But Lower Profit?

Capital Clean Energy Carriers (CCEC) stock is in focus after the company reported second quarter 2026 earnings, which showed higher sales alongside slightly lower net income and earnings per share compared with the same period last year. See our latest analysis for Capital Clean Energy Carriers. At a share price of $22.72, Capital Clean Energy Carriers has logged an 8.86% 1 month share price return and an 11.32% year to date share price return. Its 1 year total shareholder return is broadly...
NYSE:FBP
NYSE:FBPBanks

Is Stronger Q2 Earnings And Capital Returns Altering The Investment Case For First BanCorp (FBP)?

In July 2026, First BanCorp. reported second-quarter 2026 results showing higher net interest income of US$229.13 million and net income of US$96.15 million year-on-year, alongside lower net charge-offs of US$15.98 million, completion of a US$112.78 million share repurchase program, and affirmation of a US$0.20 quarterly dividend. Together, stronger earnings, reduced credit losses, ongoing dividends, and completed buybacks highlight how First BanCorp. is actively returning capital while...
NasdaqGS:WING
NasdaqGS:WINGHospitality

Wingstop (WING) Stock May Be 14% Undervalued Despite Sales Declines

Wingstop stock has fallen 61.9% over the past year, yet the current checks send mixed signals on value, with an intrinsic value estimate from a Discounted Cash Flow (DCF) approach pointing to upside while earnings based multiples screen the shares as expensive. Recent news around soft same store sales and loyalty driven promotions adds another layer to how investors may think about what a fair price for Wingstop looks like today. Wingstop is down 61.9% over the last year, which puts the...
NYSE:HRB
NYSE:HRBConsumer Services

Does H&R Block's (HRB) New Analyst Coverage Reframe Its Defensive Profile or Just Confirm Consensus?

Recently, Stephens & Co. initiated research coverage on H&R Block with an Equal-Weight rating, adding another institutional voice to the tax preparer’s analyst following. This new coverage lands after past strong earnings and guidance raised in May, potentially sharpening investor focus on the company’s defensive profile and relative valuation. Next, we’ll examine how this fresh analyst coverage and heightened visibility may influence H&R Block’s broader investment narrative. Capitalize on...
NYSE:GRMN
NYSE:GRMNConsumer Durables

Workday Stock And Other Founder Led Software Picks Worth Watching

Inflation, central bank decisions and energy prices are keeping markets on edge, which makes it harder to rely on short term signals. Founder led companies offer a different anchor. These leaders often have reputations, wealth and careers tied directly to the long term outcome of their stock. The Founder-Led Companies screener focuses on this alignment. It does not track a single sector or story, which can help you stay flexible as conditions change. In this article you will see three stocks...
NYSE:OHI
NYSE:OHIHealth Care REITs

Omega Healthcare Investors (OHI) Stock May Still Trade Below Fair Value

Omega Healthcare Investors has delivered a strong 115.8% total return over the past five years, and the latest valuation work suggests the stock may still trade below an estimate of intrinsic value based on Discounted Cash Flow, rather than looking stretched after that run. A 115.8% return over five years suggests long term holders in Omega Healthcare Investors have already been well rewarded. Any further upside case now rests on whether the current price still leaves a margin against...
NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

Upstart (UPST) Secures $4 Billion Castlelake Loan Funding Deal

Upstart Holdings (NasdaqGS:UPST) announced a new multi-year forward-flow loan agreement with Castlelake. The program totals up to US$4b in committed funding capacity for Upstart-powered loans. This is the largest forward-flow program between Upstart and Castlelake so far. Upstart Holdings operates an AI-driven lending platform that connects consumers, banks and credit unions. Access to committed funding is central for a company that depends on third-party capital providers to purchase and...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Atlassian (TEAM) Stock Still Looks Reasonable Despite Weak Cash Flow Questions

Atlassian stock has staged a sharp short term rebound but sits on a long stretch of weak returns, which contrasts with valuation checks that currently lean toward the shares looking cheap on several standard measures. Over the past 5 years, Atlassian has delivered a cumulative decline of 69.4%, which frames today’s share price near US$104 as a recovery off a much lower base rather than a long run success story. Expectations around Atlassian’s ability to convert its software revenue into...
NasdaqGS:ALLT
NasdaqGS:ALLTSoftware

US Cybersecurity Stocks Facing New AI Rules What Investors Should Watch

US cybersecurity stocks sit at the crossroads of two powerful forces. On one side are rising concerns about AI being misused in hacks and cross border data theft. On the other are signs that regulators may tighten control of high risk AI tools after recent OpenAI related incidents. That mix can pressure some AI heavy giants while potentially giving select security focused players a relative edge. This article looks at 3 US cybersecurity stocks from the screener that appear closely exposed to...
NYSE:BSX
NYSE:BSXMedical Equipment

Boston Scientific (BSX) Stock Looks Cheap On Earnings But Weak On Execution

Boston Scientific stock has fallen about 56.9% over the past year, yet the valuation checks still lean supportive, which raises the question of whether the share price has moved further than the fundamentals suggest. The roughly 56.9% decline over the last 12 months means existing shareholders have taken a heavy hit, while potential new buyers are looking at a much lower entry point. The global restructuring plan that targets lower ongoing costs can support valuation over time. However, the...
NasdaqCM:WSC
NasdaqCM:WSCConstruction

Is WillScot (WSC) Using Quick-Connect Canopies To Deepen Its Modular Ecosystem Advantage?

WillScot Holdings recently expanded its Clearspan portfolio by launching the Quick-Connect Canopy, a rapidly deployable, ISO-mounted fabric structure that creates covered workspace between compatible modular units, now available across select major U.S. markets. This product introduces a new way for customers to integrate modular buildings, storage containers and ground-level offices into weather-protected, workflow-optimized compounds for construction, industrial and event operations. Next,...
NYSE:SPNT
NYSE:SPNTInsurance

SiriusPoint (SPNT): Do Higher EPS And A New COO Redefine Its Profitability Playbook?

SiriusPoint Ltd. has reported past second-quarter 2026 results showing revenue of US$744.1 million versus US$748.2 million a year earlier, with net income rising to US$68.6 million and diluted earnings per share from continuing operations increasing to US$0.58 from US$0.50. Despite slightly lower revenue, SiriusPoint delivered higher profitability and has also strengthened its leadership bench with the appointment of a new Chief Operating Officer to drive technology and operational...
NYSE:AVB
NYSE:AVBResidential REITs

AvalonBay (AVB) Stock May Be 32% Undervalued Despite Raised Guidance

AvalonBay Communities has delivered a 15.1% total return over the past 3 years, yet the valuation picture is not straightforward. An intrinsic value estimate based on a Discounted Cash Flow (DCF) approach points to upside, while broader checks look more mixed. At the same time, market-based multiples suggest the stock is trading at about the right level, which puts extra focus on which lens investors choose to rely on. Over the last 3 years, AvalonBay Communities has returned 15.1%, which is...
NYSE:CLX
NYSE:CLXHousehold Products

Clorox (CLX) Stock Trades At A Discount To Fair Value

Clorox stock is trading at about US$99.63 after a difficult few years for shareholders, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the earnings multiples currently point to the shares looking inexpensive rather than stretched. Clorox has delivered a decline of roughly 29.1% over the past 5 years, which means the share price has lagged while the latest valuation checks now suggest more supportive pricing. Expectations that Clorox can continue to convert earnings into...